ST
Sarepta Therapeutics Inc.
🇬🇧XLON.0L35United KingdomNot reported
$20.37USDdown -0.39 (-1.88%)ClosedEnd of day2:46 AM
Price$20.37-0.39 (-1.88%)
Profile
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- Not reported
- CUSIP
- Not reported
Company
- Employees
- 1,372
- Headquarters
- Cambridge, United Kingdom
- Website
- https://www.sarepta.com
Market
- Shares outstanding
- 66.8M
- Market cap
- $1.36B
Highlights
- Market cap
- $1.39B
- EPS LTM
- -R$4.06calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- R$2.41B+47.15%up year on year
- Net income
- -R$271.51M-322.84%down year on year
- Gross margin
- 75.3%-11.82%down year on year
- Free cash flow
- -R$381.1M+18.98%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.